ABCG2 and nonpapillary renal cell carcinoma: In contrast, some studies suggested that ABCG2 C421A polymorphism may be useful as a biomarker for the prediction of susceptibility to diffuse large B-cell lymphoma [33], lymphoma [34], and nonpapillary renal cell carcinoma [35].